United States · FDA National Drug Code directory
Papaverine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72516-024_2b4bd8c6-2b93-d435-e063-6394a90ae742
- Product NDC
- 72516-024
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Papaverine Hydrochloride
- Labeler
- Oryza Pharmaceuticals Inc.
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start / end (source format)
- 20210201
- Source listing expiry
- 20261231
Source-listed ingredients
- PAPAVERINE HYDROCHLORIDE — 30 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 VIAL in 1 CARTON (72516-024-10) / 2 mL in 1 VIAL · 72516-024-10
- 25 VIAL in 1 CARTON (72516-024-25) / 2 mL in 1 VIAL · 72516-024-25
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →